Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Item
http://www.wikidata.org/entity/Q41092886
Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9.Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.Precision genome editing in the CRISPR era.CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients.Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy.Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy.Cells of Matter-In Vitro Models for Myotonic Dystrophy.
P2860

Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Item
http://www.wikidata.org/entity/Q41092886
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Genome Therapy of Myotonic Dys ...... Autologous Stem Cell Therapy.
@en
type
label
Genome Therapy of Myotonic Dys ...... Autologous Stem Cell Therapy.
@en
prefLabel
Genome Therapy of Myotonic Dys ...... Autologous Stem Cell Therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Genome Therapy of Myotonic Dys ...... Autologous Stem Cell Therapy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932